Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verona Pharma PLC
Long-Term Debt Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Long-Term Debt
$120m
CAGR 3-Years
192%
CAGR 5-Years
172%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Long-Term Debt
ÂŁ13.6B
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Long-Term Debt
$28.2B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%
Indivior PLC
LSE:INDV
Long-Term Debt
$268m
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Long-Term Debt
$1.1B
CAGR 3-Years
12%
CAGR 5-Years
59%
CAGR 10-Years
15%
Dechra Pharmaceuticals PLC
LSE:DPH
Long-Term Debt
ÂŁ500.6m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
17%

See Also

What is Verona Pharma PLC's Long-Term Debt?
Long-Term Debt
120m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Long-Term Debt amounts to 120m USD.

What is Verona Pharma PLC's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
172%

Over the last year, the Long-Term Debt growth was 503%. The average annual Long-Term Debt growth rates for Verona Pharma PLC have been 192% over the past three years , 172% over the past five years .

Back to Top